Medicus Pharma (MDCX) Other Operating Expenses (2024 - 2025)

Medicus Pharma (MDCX) reported Other Operating Expenses of -$996039.0 for Q4 2025, up 40.88% quarter-over-quarter from -$1.7 million in Q3 2025.

Medicus Pharma (MDCX) Other Operating Expenses (2024 - 2025) Analysis & Trends

Medicus Pharma has reported Other Operating Expenses for 2 years, with the latest figure at -$996039.0 in Q4 2025.

For the quarter ending Q4 2025, Other Operating Expenses changed N/A year-over-year to -$996039.0; the trailing twelve-month figure through Dec 2025 stood at -$2.7 million (down 575.2% YoY), and the FY2025 full-year result was $7.7 million, changed N/A from the prior year.
Other Operating Expenses for Q4 2025 stood at -$996039.0, up from -$1.7 million in the prior quarter.
The five-year high for Other Operating Expenses was $564145.0 in Q3 2024, with the low at -$1.7 million in Q3 2025.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)
1	Gsk	93,699,046.73 Bn	93,699,041.77 Bn	7.76 Bn
2	Eli Lilly	1,012.06 Bn	1,006.77 Bn	16.22 Bn
3	Johnson & Johnson	560.67 Bn	538.62 Bn	15.96 Bn
4	AbbVie	402.20 Bn	392.85 Bn	10.78 Bn
5	Merck	298.59 Bn	292.94 Bn	12.09 Bn
6	Amgen	188.77 Bn	176.74 Bn	5.87 Bn
7	Gilead Sciences	160.22 Bn	152.49 Bn	5.52 Bn
8	Pfizer	148.19 Bn	135.42 Bn	-1.21 Bn
9	Bristol Myers Squibb	116.72 Bn	106.26 Bn	8.07 Bn
10	Medicus Pharma	6.05 Mn	6.15 Mn	-

Download Data